Great Tree Pharmacy Co., Ltd. Statistics
Great Tree Pharmacy Co., Ltd. (6469) Stock Statistics & Valuation Metrics
Total Valuation
Great Tree Pharmacy Co., Ltd. has a market cap or net worth of TWD 9.20B. The enterprise value is TWD 16.60B.
- Market Cap
- TWD 9.20B
- Enterprise Value
- TWD 16.60B
Share Statistics
Great Tree Pharmacy Co., Ltd. has 159,085,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 159,085,160
- Owned by Insiders
- ―
- Owned by Institutions
- 2.11%
Financial Efficiency
Great Tree Pharmacy Co., Ltd.’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 4.81%.
- Return on Equity (ROE)
- 0.15
- Return on Assets (ROA)
- 0.04
- Return on Invested Capital (ROIC)
- 4.81%
- Return on Capital Employed (ROCE)
- 0.08
- Revenue Per Employee
- 42.37M
- Profits Per Employee
- 1.35M
- Employee Count
- 446
- Asset Turnover
- 1.37
- Inventory Turnover
- 3.65
Valuation Ratios
The current PE Ratio of Great Tree Pharmacy Co., Ltd. is 16.85. Great Tree Pharmacy Co., Ltd.’s PEG ratio is -0.58.
- PE Ratio
- 16.85
- PS Ratio
- 0.49
- PB Ratio
- 2.33
- Price to FCF
- 14.87
- Price to Operating Cash Flow
- 8.84
- PEG Ratio
- -0.58
Income Statement
In the last 12 months, Great Tree Pharmacy Co., Ltd. had revenue of 18.90B and earned 600.42M in profits. Earnings per share was 4.01.
- Revenue
- 18.90B
- Gross Profit
- 5.42B
- Operating Income
- 689.33M
- Pretax Income
- 743.99M
- Net Income
- 600.42M
- EBITDA
- 1.71B
- Earnings Per Share (EPS)
- 4.01
Cash Flow
In the last 12 months, operating cash flow was 965.15M and capital expenditures -341.75M, giving a free cash flow of 623.39M billion.
- Operating Cash Flow
- 965.15M
- Free Cash Flow
- 623.39M
- Free Cash Flow per Share
- 4.26
Dividends & Yields
Great Tree Pharmacy Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 5.46%
- Dividend Per Share
- ―
- Dividend Yield
- 5.46%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 6.73%
- Earnings Yield
- 6.05%
Stock Price Statistics
- Beta
- 0.12
- 52-Week Price Change
- -44.81%
- 50-Day Moving Average
- 65.21
- 200-Day Moving Average
- 70.17
- Relative Strength Index (RSI)
- 24.88
- Average Volume (3m)
- 402.34K
Important Dates
Great Tree Pharmacy Co., Ltd. upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 10, 2026
- Next Earnings Date
- Nov 17, 2026
- Ex-Dividend Date
- ―
Financial Position
Great Tree Pharmacy Co., Ltd. as a current ratio of 1.63, with Debt / Equity ratio of 180.47%
- Current Ratio
- 1.63
- Quick Ratio
- 0.83
- Debt to Market Cap
- 0.18
- Net Debt to EBITDA
- 3.10
- Interest Coverage Ratio
- 8.03
Taxes
In the past 12 months, Great Tree Pharmacy Co., Ltd. has paid 162.49M in taxes.
- Income Tax
- 162.49M
- Effective Tax Rate
- 0.22
Enterprise Valuation
Great Tree Pharmacy Co., Ltd. EV to EBITDA ratio is 9.39, with an EV/FCF ratio of 22.84.
- EV to Sales
- 0.75
- EV to EBITDA
- 9.39
- EV to Free Cash Flow
- 22.84
- EV to Operating Cash Flow
- 14.75
Balance Sheet
Great Tree Pharmacy Co., Ltd. has TWD 2.53B in cash and marketable securities with TWD 6.44B in debt, giving a net cash position of -TWD 3.90B billion.
- Cash & Marketable Securities
- TWD 2.53B
- Total Debt
- TWD 6.44B
- Net Cash
- -TWD 3.90B
- Net Cash Per Share
- -TWD 24.53
- Tangible Book Value Per Share
- TWD 24.98
Margins
Gross margin is 28.55%, with operating margin of 2.75%, and net profit margin of 2.71%.
- Gross Margin
- 28.55%
- Operating Margin
- 2.75%
- Pretax Margin
- 3.19%
- Net Profit Margin
- 2.71%
- EBITDA Margin
- 7.98%
- EBIT Margin
- 3.24%
Analyst Forecast
The average price target for Great Tree Pharmacy Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 4.00%
- EPS Growth Forecast
- -22.38%
